RBC Life Sciences Inc
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.
RBC Life Sciences Inc (RBCL) - Total Assets
Latest total assets as of September 2017: $11.85 Million USD
Based on the latest financial reports, RBC Life Sciences Inc (RBCL) holds total assets worth $11.85 Million USD as of September 2017.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
RBC Life Sciences Inc - Total Assets Trend (1996–2016)
This chart illustrates how RBC Life Sciences Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
RBC Life Sciences Inc - Asset Composition Analysis
Current Asset Composition (December 2016)
RBC Life Sciences Inc's total assets of $11.85 Million consist of 70.2% current assets and 29.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.4% |
| Accounts Receivable | $1.17 Million | 10.6% |
| Inventory | $4.15 Million | 37.8% |
| Property, Plant & Equipment | $977.58K | 8.9% |
| Intangible Assets | $20.11K | 0.2% |
| Goodwill | $2.16 Million | 19.7% |
Asset Composition Trend (1996–2016)
This chart illustrates how RBC Life Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RBC Life Sciences Inc's current assets represent 70.2% of total assets in 2016, an increase from 35.7% in 1996.
- Cash Position: Cash and equivalents constituted 13.4% of total assets in 2016, up from 2.4% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, a decrease from 50.0% in 1996.
- Asset Diversification: The largest asset category is inventory at 37.8% of total assets.
RBC Life Sciences Inc Competitors by Total Assets
Key competitors of RBC Life Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
RBC Life Sciences Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - RBC Life Sciences Inc generates 2.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - RBC Life Sciences Inc is currently not profitable relative to its asset base.
RBC Life Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 2.29 | 1.85 |
| Quick Ratio | 0.55 | 1.10 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.51 Million | $ 4.44 Million | $ 5.12 Million |
RBC Life Sciences Inc - Advanced Valuation Insights
This section examines the relationship between RBC Life Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -3.0% |
| Total Assets | $10.96 Million |
| Market Capitalization | $0.94 USD |
Valuation Analysis
Below Book Valuation: The market values RBC Life Sciences Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: RBC Life Sciences Inc's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for RBC Life Sciences Inc (1996–2016)
The table below shows the annual total assets of RBC Life Sciences Inc from 1996 to 2016.
| Year | Total Assets | Change |
|---|---|---|
| 2016-12-31 | $10.96 Million | -2.96% |
| 2015-12-31 | $11.30 Million | -29.38% |
| 2014-12-31 | $16.00 Million | -8.77% |
| 2013-12-31 | $17.53 Million | -2.67% |
| 2012-12-31 | $18.01 Million | -4.31% |
| 2011-12-31 | $18.83 Million | +2.63% |
| 2010-12-31 | $18.34 Million | -1.45% |
| 2009-12-31 | $18.61 Million | -5.84% |
| 2008-12-31 | $19.77 Million | +3.17% |
| 2007-12-31 | $19.16 Million | +41.75% |
| 2006-12-31 | $13.52 Million | +6.53% |
| 2005-12-31 | $12.69 Million | +13.74% |
| 2004-12-31 | $11.15 Million | +4.79% |
| 2003-12-31 | $10.64 Million | -4.13% |
| 2002-12-31 | $11.10 Million | -11.81% |
| 2001-12-31 | $12.59 Million | +17.16% |
| 2000-12-31 | $10.74 Million | +17.91% |
| 1999-12-31 | $9.11 Million | +11.03% |
| 1998-12-31 | $8.21 Million | +37.17% |
| 1997-12-31 | $5.98 Million | +50.81% |
| 1996-12-31 | $3.97 Million | -- |